No Prescription |
 |
 | ||
|
Avandia Generic Rosiglitazone |
|
| ||
No Prescription » Prescription Drugs 2 » Avandia Generic Rosiglitazone Rosiglitazone is an anti-diabetic drug (thiazolidinedione-type also called "glitazones") used with a proper diet and exercise program to control high blood sugar in patients with type 2 diabetes (non-insulin-dependent diabetes). Rosiglitazone works by helping to restore your body's proper response to insulin thereby lowering your blood sugar. Effectively controlling high blood sugar helps prevent heart disease strokes kidney disease blindness and circulation problems as well as sexual function problems (impotence).Rosiglitazone is best used only when other medications (metformin) cannot be taken.How to use Rosiglitazone OralRead the Medication Guide and the Patient Information Leaflet available from your pharmacist before you start taking this medication and each time you get a refill. If you have any questions consult your doctor or pharmacist.Take this medication by mouth with or without food usually once or twice daily or as directed by your doctor. Dosage is based on your medical condition response to therapy and if you are taking other anti-diabetic drugs.Use this medication regularly in order to get the most benefit from it. Remember to use it at the same time(s) each day. Monitor blood glucose levels on a regular basis.It may take up to 2 to 3 months before the full benefit of this drug takes effect.Take all other medications for diabetes as directed by your doctor. Buy Avandia Generic Rosiglitazone and other Prescription Drugs 2 products online at Medstore. Buy Online at Medstore - Click Here!
About Avandia Generic Rosiglitazone: Product Type: Prescription Drugs 2 Avandia ( Generic Rosiglitazone ) Avandia (Generic Rosiglitazone) Generic Rosiglitazone 8mg 28 tabs 4mg 28 Tablets Generic Rosiglitazone Avandia
View more Prescription Drugs 2 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
